Cardiology: Inpatient Reading List

The Copyright law of the United States (Title 17, United States Code) governs the making of photocopies or other reproductions of copyright material. Under certain conditions specified in the law, libraries and archives are authorized to furnish a photocopy or other reproduction, which is not to be "used for any purposes other than private study, scholarship or research." If a user makes a request for, or later uses, a photocopy or reproduction for purposes in excess of "fair use", that user may be liable for copyright infringement.

• The ACC / AHA Guidelines (all available on www.acc.org)  Please see below for all the guidelines since 2000.
• Harrison’s Principles of Internal Medicine (Parts 2 & 8)

Secondary Prevention

• AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
  

Coronary Artery Disease

• AHA/ACC Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction

Heart Failure

• AHA/ACC Practice Guidelines for Evaluation and Management of Chronic Heart Failure in the Adult

• Cohn JN, Tognoni G, for the Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001;345:1667-1675.
• The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821–828.
• The SOLVD Investigators.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.  N Engl J Med 1992;327:685-91. (This article is not available electronically; it can be found in print at the Galter Library.)
• Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial: the SAVE Investigators. N Engl J Med. 1992; 327: 669–677. (This article is not available electronically; it can be found in print at the Galter Library.)
• The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429–1435. (This article is not available electronically; it can be found in print at the Galter Library.)

Beta-blockers

• Gheorghiade M, Colucci WS, Swedberg K. B-blockers in chronic heart failure. (Clinician Update) Circulation 2003;107:1570-1575.
• The MERIT-HF Investigators. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)[comment]. Lancet. 353(9169):2001-7, 1999 Jun 12.
• The CIBIS-II Investigators. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial. Lancet. 353(9146):9-13, 1999 Jan 2.
• Packer M. Bristow MR. Cohn JN. Colucci WS. Fowler MB. Gilbert EM. Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. New England Journal of Medicine. 334(21):1349-55, 1996.
• Packer M. Fowler MB. Roecker EB. Coats AJ. Katus HA. Krum H. Mohacsi P. Rouleau JL. Tendera M. Staiger C. Holcslaw TL. Amann-Zalan I. DeMets DL. Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 106(17):2194-9, 2002 Oct 22.
• Packer M, Coats AJS, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8.

Aldosterone blockers

• Pitt B. Remme W. Zannad F. Neaton J. Martinez F. Roniker B. Bittman R. Hurley S. Kleiman J. Gatlin M. Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348(14):1309-21.
• Pitt B, Zannad F, Remme WJ, et al. for the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709–717.

Digoxin

• Rathore SS. Curtis JP. Wang Y. Bristow MR. Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA. 2003;289(7):871-8.
• Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997; 336: 525–533.

Device therapy

• Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
• Bradley DJ. Bradley EA. Baughman KL. Berger RD. Calkins H. Goodman SN. Kass DA. Powe NR. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA. 2003;289:730-40.
• Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. J Card Fail 2000;6:276-85. (This article is not available electronically or in print at the Galter Library; it can be reqested through interlibrary loan.)
• Kaneko Y. Floras JS. Usui K. Plante J. Tkacova R. Kubo T. Ando S. Bradley TD. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. New England Journal of Medicine. 348(13):1233-41, 2003 Mar 27.
• McCullough PA. Nowak RM. McCord J. Hollander JE. Herrmann HC. Steg PG. Duc P. Westheim A. Omland T. Knudsen CW. Storrow AB. Abraham WT. Lamba S. Wu AH. Perez A. Clopton P. Krishnaswamy P. Kazanegra R. Maisel AS. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002; 106(4):416-22.

Diastolic Heart Failure

• Zile MR. Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation. 2002;105(12):1503-8.
• Vitarelli A. Gheorghiade M. Diastolic heart failure: standard Doppler approach and beyond. Am J Cardiol. 81(12A):115G-121G, 1998 Jun 18.
• Vasan RS. Benjamin EJ. Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol. 26(7):1565-74, 1995 Dec.

Valvular Heart Disease

• Valvular Heart Disease, Guidelines for the Management of Patients with. ACC/AHA 2006
  

Arrhythmias

• Atrial Fibrillation: 2006 Guidelines for Management of Patients with. ACC/AHA/ESC 2006
• Ventricular Arrhythmias and Sudden Cardiac Death: 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. ACC/AHA/ESC 2006
• ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices
• The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.  The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-11. (This article is not available electronically; it can be found in print at the Galter Library.)
• Stroke Prevention in Atrial Fibrillation Investigators.  Stroke prevention in atrial fibrillation study.  Circulation 1991;84:527-53 (Available electronically through Journals@Ovid; no direct link available; search E-Journals.)

Galter Health Sciences Library · Feinberg School of Medicine · Northwestern University
303 E. Chicago Avenue · Chicago, IL 60611-3008
Phone 312-503-8126 · Fax 312-503-1204
Copyright © 1999-2006 Northwestern University. World Wide Web Disclaimer and University Policy Statements

38.103.63.16